NCT04637529

Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain

National, Multicentre, Randomized, Double-blind, Double-dummy Phase II Clinical Trial to Evaluate the Efficacy and Safety of S (+) - Ibuprofen for Pain Control in Individuals With Osteoarthritis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 176 (actual)
• Sponsor: Apsen Farmaceutica S.A. · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy of S (+) - ibuprofen compared to an active treatment for pain control in individuals diagnosed with osteoarthritis.

Conditions

• Osteoarthritis

Interventions

Type	Name	Description
DRUG	S (+) - Ibuprofen	S (+) - Ibuprofen + placebo of Ibuvix®
DRUG	Ibuvix® - ibuprofen	Ibuvix® + placebo of S(+) - Ibuprofen

Timeline

• Start date: 2022-08-05
• Primary completion: 2023-06-30
• Completion: 2023-06-30
• First posted: 2020-11-19
• Last updated: 2023-07-17

Locations

1 site across 1 country: Brazil